NCT02858973View on ClinicalTrials.gov

A Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics of Multiple Doses of Q203 in Normal Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

May 31, 2018

Study Completion Date

May 8, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

Q203

DRUG

Placebo

Trial Locations (1)

68502

Lincoln

All Listed Sponsors
lead

Qurient Co., Ltd.

INDUSTRY

NCT02858973 - A Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics of Multiple Doses of Q203 in Normal Healthy Male and Female Volunteers | Biotech Hunter | Biotech Hunter